T. Rowe Price Associates’s VIROPHARMA INC VPHM Stock Holding History

T. Rowe Price Associates’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-228,200	Closed	-$11.4M	–	2560
2013 Q4	$11.4M	Sell	228,200 -402,000	-64%	-$18M	﹤0.01%	1253
2013 Q3	$24.8M	Sell	630,200 -1,018,000	-62%	-$33.3M	0.01%	1024
2013 Q2	$47.2M	Buy	+1,648,200	New	+$43.5M	0.01%	805

T. Rowe Price Associates's VPHM Position: Q1 2014 in Review

T. Rowe Price Associates sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 228,200 shares — an estimated $11.4M sold.

T. Rowe Price Associates first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $47.2M in Q2 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

T. Rowe Price Associates reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
T. Rowe Price Associates sold 228,200 VIROPHARMA INC shares in Q1 2014, an estimated $11.4M.
T. Rowe Price Associates first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
T. Rowe Price Associates's VIROPHARMA INC position peaked at $47.2M in Q2 2013.
0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.